Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Performance Outlook 2026–2030: Revenue to Hit $90.76 Billion at 10.6% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical contract development and manufacturing organization (cmo) market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market be in 2030 compared with 2026?
The pharmaceutical contract development and manufacturing organization (CMO) market has witnessed substantial growth over recent years. Forecasts indicate that this market will expand from $54.73 billion in 2025 to reach $60.7 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this expansion has been driven by factors such as enhanced research and development spending by pharmaceutical companies, the increasing occurrence of chronic illnesses, a rise in the demand for generic medicines, innovations in drug production technology, and a heightened emphasis on preclinical and clinical studies.
The pharmaceutical contract development and manufacturing organization (cmo) market is projected for significant expansion in the coming years. This market is anticipated to reach $90.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.6%. This projected growth is driven by several factors, including the increasing adoption of personalized medicine, a rising need for biologics and intricate therapeutics, the broadening of CDMO capabilities in new markets, the incorporation of digital technologies into drug development processes, and a surge in strategic collaborations and acquisitions within the pharmaceutical industry. Key trends expected during this period involve the outsourcing of drug development and manufacturing activities, an expansion of CDMO service offerings, a strong emphasis on regulatory adherence and quality assurance, the formation of strategic alliances between pharmaceutical firms and CDMOs, and the integration of sophisticated analytical and testing solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
What Drivers Are Guiding Growth Patterns In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
A rising number of patent expirations is anticipated to boost the pharmaceutical contract development and manufacturing market. Patent expiration signifies the termination of legally safeguarded exclusive entitlements bestowed upon an inventor or patent holder to produce, market, or utilize an invention for a defined duration. The pharmaceutical contract development and manufacturing services facilitate the rapid creation and output of generic drugs, enabling their market introduction following patent expiration. For instance, in February 2024, as reported by DrugTimes, a Chinese-based company focused on the pharmaceutical and biotech industry, it is projected that by 2037, more than 25 products will become off-patent. This could result in a collective revenue reduction exceeding $236.4 billion, calculated from 2024 sales. Consequently, the rise in patent expirations is a key driver for the pharmaceutical contract development and manufacturing market.
Which Segments Are Driving Activity In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
3) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
How Are New Market Trends Shaping The Landscape Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Companies operating significantly within the pharmaceutical contract development and manufacturing market are rolling out new services, such as the DevPack, to bolster their service portfolios and address the changing requirements of the industry. The DevPack functions as a service optimized across multiple collaborators to establish a standardized collection of data for various development process steps. For example, in May 2023, ASM Research Chemicals, a Germany-based entity providing contract research and manufacturing services, introduced DevPack, a new development pack service specifically designed for the manufacturing of active pharmaceutical ingredients (APIs). This DevPack service, which is optimized through ten core partners, furnishes a standardized dataset for development procedures. It facilitates the streamlining of API research, development, and subsequent scale-up. Ideal for CMOs and pharmaceutical enterprises seeking swift early-stage manufacturing route development for APIs, this service also extends its support to analytical development and regulatory submissions.
Which Key Market Players Are Investing In Expansion And Innovation Within The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market are Lonza Group, Catalent Inc, WuXi AppTec Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Access The Complete Report For Deeper Market Insights:
Which Regions Are Poised For Strategic Growth In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2825&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
